Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2019, Article ID 3139278, 11 pages
https://doi.org/10.1155/2019/3139278
Research Article

Correlations between Traditional and Nontraditional Indicators of Adiposity, Inflammation, and Monocyte Subtypes in Patients with Stable Coronary Artery Disease

1Graduate Program in Health Sciences (Cardiology), Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology (IC/FUC), Princesa Isabel Avenue, 395, Porto Alegre, Rio Grande do Sul 90040-371, Brazil
2Graduate Program in Nutrition Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Sarmento Leite Street, 245, Porto Alegre, Rio Grande do Sul 90050-170, Brazil
3Institute of Research,Coracao Hospital (HCor), Abílio Soares Street, 250, São Paulo, São Paulo 04004-05, Brazil

Correspondence should be addressed to Aline Marcadenti; moc.liamg@enila.itnedacram

Received 18 January 2019; Revised 30 May 2019; Accepted 10 June 2019; Published 3 July 2019

Academic Editor: Monica Nannipieri

Copyright © 2019 Silvia Bueno Garofallo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Z. Rocha and P. Libby, “Obesity, inflammation, and atherosclerosis,” Nature Reviews Cardiology, vol. 6, no. 6, pp. 399–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. C. Calder, N. Ahluwalia, F. Brouns et al., “Dietary factors and low-grade inflammation in relation to overweight and obesity,” British Journal of Nutrition, vol. 106, no. S3, pp. S5–S78, 2011. View at Publisher · View at Google Scholar
  3. M. Alvehus, J. Burén, M. Sjöström, J. Goedecke, and T. Olsson, “The human visceral fat depot has a unique inflammatory profile,” Obesity, vol. 18, no. 5, pp. 879–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Torriani, C. M. Gill, S. Daley, A. L. Oliveira, D. C. Azevedo, and M. A. Bredella, “Compartmental neck fat accumulation and its relation to cardiovascular risk and metabolic syndrome,” American Journal of Clinical Nutrition, vol. 100, no. 5, pp. 1244–1251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. S. Kahn, “The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison,” BMC Cardiovasc Disorders, vol. 5, no. 1, p. 26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Amato, C. Giordano, M. Galia et al., “Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk,” Diabetes Care, vol. 33, no. 4, pp. 920–922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Brundavani, S. R. Murthy, and A. V. Kurpad, “Estimation of deep-abdominal-adipose-tissue (DAAT) accumulation from simple anthropometric measurements in Indian men and women,” European Journal of Clinical Nutrition, vol. 60, no. 5, pp. 658–666, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-J. Park, J. Kim, S. E. Park et al., “Increased risk of subclinical atherosclerosis associated with high visceral adiposity index in apparently healthy Korean adults: the Kangbuk samsung health study,” Annals of Medicine, vol. 48, no. 6, pp. 410–416, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. D. R. Wanderley Rocha, A. R. Jorge, V. B. Braulio, A. K. Arbex, and A. Marcadenti, “Visceral adiposity measurements, metabolic, and inflammatory profile in obese patients with and without type 2 diabetes mellitus: a cross-sectional analysis,” Current Diabetes Reviews, vol. 13, no. 1, pp. 11–18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ladeiras-Lopes, F. Sampaio, N. Bettencourt et al., “The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events,” Revista Española de Cardiología (English Edition), vol. 70, no. 5, pp. 331–337, 2017. View at Publisher · View at Google Scholar
  11. R. Huxley, S. Mendis, E. Zheleznyakov, S. Reddy, and J. Chan, “Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature,” European Journal of Clinical Nutrition, vol. 64, no. 1, pp. 16–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Cameron, D. J. Magliano, and S. Söderberg, “A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality,” Obesity Reviews, vol. 14, no. 1, pp. 86–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Shantsila, B. Wrigley, L. Tapp et al., “Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology,” Journal of Thrombosis and Haemostasis, vol. 9, no. 5, pp. 1056–1066, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Weber, E. Shantsila, M. Hristov et al., “Role and analysis of monocyte subsets in cardiovascular disease: joint consensus document of the european society of cardiology (ESC) working groups “atherosclerosis & vascular biology” and “thrombosis”,” Thrombosis and Haemostasis, vol. 116, no. 10, pp. 626–637, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Hristov, T. Leyendecker, C. Schuhmann et al., “Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease,” Thrombosis and Haemostasis, vol. 104, no. 8, pp. 412–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. K. Swirski, P. Libby, E. Aikawa et al., “Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 195–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. S. Rogacev, B. Cremers, A. M. Zawada et al., “CD14++CD16+ monocytes independently predict cardiovascular events,” Journal of the American College of Cardiology, vol. 60, no. 16, pp. 1512–1520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Kintscher, S. Wakino, S. Kim, E. Fleck, W. A. Hsueh, and R. E. Law, “Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes,” Hypertension, vol. 37, no. 2, pp. 587–593, 2001. View at Publisher · View at Google Scholar
  19. M. E. Frigolet, N. Torres, and A. R. Tovar, “The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity,” Journal of Nutritional Biochemistry, vol. 24, no. 12, pp. 2003–2015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. V. L. Portal, M. M. Markoski, A. S. de Quadros et al., “Effect of polymorphisms in the CD36 and STAT3 genes on different dietary interventions among patients with coronary artery disease: study protocol for a randomized controlled trial,” Trials, vol. 17, no. 1, p. 437, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Babb, A. Malarcher, G. Schauer, K. Asman, and A. Jamal, “Quitting smoking among adults—United States, 2000–2015,” MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 52, pp. 1457–1464, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. C. L. Craig, A. L. Marshall, M. Sjöström et al., “International physical activity questionnaire: 12-country reliability and validity,” Medicine & Science in Sports & Exercise, vol. 35, no. 8, pp. 1381–1395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. V. B. Malachias, M. A. M. Gomes, F. Nobre, A. Alessi, A. D. Feitosa, and E. B. Coelho, “7th Brazilian guideline of arterial hypertension: chapter 2—diagnosis and classification,” Arquivos brasileiros de cardiologia, vol. 107, no. 3, pp. 7–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. American Diabtes Association, “Chapter 2: classification and diagnosis of diabetes,” Diabetes Care, vol. 40, no. 1, pp. S11–S24, 2017. View at Google Scholar
  25. A. L. Catapano, G. De Backer, I. Graham et al., “ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and european atherosclerosis society (EAS) developed with the special contribution of the european assocciation for cardiovascular prevention & rehabilitation (EACPR),” Atherosclerosis, vol. 253, pp. 281–344, 2016. View at Google Scholar
  26. Roche, Products and Solutions, Roche, Basel, Switzerland, 2015, http://www.cobas.com/content/dam/cobas_com/pdf/lists/Products-Solutions-2015-interactive.pdf.
  27. Siemens Sysmex Systems, https://usa.healthcare.siemens.com/hemostasis/systems/sysmex-ca-620-660-systems.
  28. E. Morgan, R. Varro, H. Sepulveda et al., “Cytometric bead array: a multiplexed assay platform with applications in various areas of biology,” Clinical Immunology, vol. 110, no. 3, pp. 252–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-W. Lee, E. Cho, M.-G. Kim, S.-K. Jo, W. Y. Cho, and H. K. Kim, “Proinflammatory CD14+CD16+ monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease,” Kidney Research and Clinical Practice, vol. 32, no. 4, pp. 147–152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Ulrich, G. H. Heine, M. K. Gerhart, H. Köhler, and M. Girndt, “Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients,” American Journal of Transplantation, vol. 8, no. 1, pp. 103–110, 2008. View at Google Scholar
  31. K. S. Rogacev, C. Ulrich, L. Blomer et al., “Monocyte heterogeneity in obesity and subclinical atherosclerosis,” European Heart Journal, vol. 31, no. 3, pp. 369–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. G. R. Dagenais, Q. Yi, J. F. E. Mann, J. Bosch, J. Pogue, and S. Yusuf, “Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease,” American Heart Journal, vol. 149, no. 1, pp. 54–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Rothe, A. S. Herr, J. Stöhr, C. Abletshauser, G. Weidinger, and G. Schmitz, “A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease,” Atherosclerosis, vol. 144, no. 1, pp. 251–261, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. K. J. Woollard and F. Geissmann, “Monocytes in atherosclerosis: subsets and functions,” Nature Reviews Cardiology, vol. 7, no. 2, pp. 77–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. S. Bonder, J. J. Finlay-jones, and P. H. Hart, “Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production: role of a functional interleukin-2 receptor γ-chain,” Immunology, vol. 96, no. 4, pp. 529–536, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. V. L. King, S. J. Szilvassy, and A. Daugherty, “Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 3, pp. 456–461, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Gupta, A. M. Pablo, X. C. Jiang, N. Wang, A. R. Tall, and C. Schindler, “IFN-gamma potentiates atherosclerosis in ApoE knock-out mice,” Journal of Clinical Investigation, vol. 99, no. 11, pp. 2752–2761, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. R. de Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries, “Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes,” Journal of Experimental Medicine, vol. 174, no. 5, pp. 1209–1220, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hafez, S. El-Masry, N. Musa et al., “Relationship between visceral obesity and plasma fibrinogen in obese children,” Journal of Pediatric Endocrinology and Metabolism, vol. 29, no. 3, pp. 289–296, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Preis, J. M. Massaro, U. Hoffmann et al., “Neck circumference as a novel measure of cardiometabolic risk: the framingham heart study,” Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 8, pp. 3701–3710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. C. Seidell, T. S. Han, E. J. M. Feskens, and M. E. J. Lean, “Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus,” Journal of Internal Medicine, vol. 242, no. 5, pp. 401–406, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. B. L. Heitmann, P. Frederiksen, and L. Lissner, “Hip circumference and cardiovascular morbidity and mortality in men and women,” Obesity Research, vol. 12, no. 3, pp. 482–487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. B. L. Heitmann and L. Lissner, “Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality,” Obesity Reviews, vol. 12, no. 6, pp. 478–481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K. L. Timmerman, M. G. Flynn, P. M. Coen, M. M. Markofski, and B. D. Pence, “Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?” Journal of Leukocyte Biology, vol. 84, no. 5, pp. 1271–1278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Shantsila, L. D. Tapp, B. J. Wrigley et al., “Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis,” Atherosclerosis, vol. 234, no. 1, pp. 4–10, 2014. View at Publisher · View at Google Scholar · View at Scopus